East Meadow, NY, United States of America

Matthew T Canning

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Applied Genetics Incorporated Dermatics. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew T Canning. Retrieved from https://idiyas.com/inventor/matthew-t-canning

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Certainly! Here is the article about inventor Matthew T Canning:

Title: Unveiling the Innovations of Matthew T Canning in East Meadow, NY

Introduction:

Matthew T Canning is a distinguished inventor based in East Meadow, NY, whose groundbreaking work in the field of inflammation reversal and inhibition has brought about revolutionary advancements in medical science. With an impressive patent under his belt, Matthew is a leading figure in the quest for novel solutions to combat inflammation-related disorders.

Latest Patents:

Matthew T Canning holds a notable patent for compositions and methods aimed at reversing and inhibiting inflammation by targeting prostaglandin and COX-2 production. This innovative approach utilizes indolequinazoline alkaloids, such as rutaecarpine, evodiamine, and dehydroevodiamine, often in conjunction with butylated hydroxytoluene.

Career Highlights:

Currently affiliated with Applied Genetics Incorporated Dermatics, Matthew T Canning continues to spearhead research and development efforts in the field of inflammation modulation. His expertise and dedication have significantly contributed to the advancement of therapeutic strategies for various inflammatory conditions.

Collaborations:

In his pursuit of scientific excellence, Matthew T Canning collaborates closely with esteemed colleagues such as Daniel B Yarosh and David A Brown. Together, they form a dynamic team dedicated to exploring innovative pathways for combating inflammation and enhancing patient outcomes.

Conclusion:

In conclusion, Matthew T Canning stands out as a visionary inventor whose work has the potential to reshape the landscape of inflammation treatment. His relentless pursuit of excellence, coupled with his collaborative efforts, underscores his commitment to driving meaningful change in the field of medical research. East Meadow, NY is indeed privileged to be home to such a pioneering figure in the realm of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…